Is AtaiBeckley Inc. (ATAI) the Hidden Penny Stock to Invest In?

AtaiBeckley Inc. (NASDAQ:ATAI) is among the hidden penny stocks to invest in. On June 8, H.C. Wainwright maintained a Buy rating on AtaiBeckley Inc. (NASDAQ:ATAI) with a price target of $25. With the highest 1-year price target among analysts, the firm’s estimate implies 561.38% upside potential.

This comes after H.C. Wainwright hosted the company’s management on June 2, featuring the CEO, CFO, and VP Investor Relations. The discussion revolved around BPL-003, which remains the key value driver as the company advances the Phase 3 program (ReConnection) in treatment-resistant depression, the firm noted. That said, the firm continues to view BPL-003 among the most differentiated short-duration psychedelic assets in development. Indeed, AtaiBeckley Inc. (NASDAQ:ATAI) is among the hidden penny stocks to buy.

Citi Lifts Price Target on Marvell Technology, Inc. (MRVL)

Source:unsplash

Back on May 28, AtaiBeckley Inc. (NASDAQ:ATAI) announced the launch of its Patient Impact Grant Program. Dedicated to improving mental health outcomes, the initiative will provide three $20,000 grants to NGOs. This is in addition to the company’s drug development activities. As said by CMO Kevin Craig,

“Real progress in mental health doesn’t happen in isolation – it happens when we innovate responsibly, listen to patients, and invest in the people driving change on the ground.”

AtaiBeckley Inc. (NASDAQ:ATAI), founded in 2018, is a New York-based clinical-stage biopharmaceutical company providing mental health treatments in the United States, Germany, and Canada.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.